From January 1, 2024 to March 31, 2024, the company has repurchased 8,575,800 shares, representing 1.67% for CNY 70.58 million. With this, the company has completed the repurchase of 8,575,800 shares, representing 1.67% for CNY 70.58 million under the buyback announced on October 29, 2023.
Shanghai Kehua Bio-Engineering Co.,Ltd
Equities
002022
CNE000001KC9
Medical Equipment, Supplies & Distribution
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
7.34 CNY | -0.68% | -2.65% | -35.50% |
04-28 | Shanghai Kehua Bio-Engineering Co.,Ltd Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
04-15 | Kehua Bio-Engineering Gets Registration Certificates for Two Devices | MT |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-35.50% | 517M | |
-1.52% | 8.37B | |
+10.68% | 5.84B | |
+26.94% | 5.4B | |
-5.09% | 4.37B | |
-52.54% | 3.23B | |
+14.18% | 2.8B | |
+32.50% | 2.26B | |
-6.47% | 2.22B | |
-1.69% | 1.87B |
- Stock Market
- Equities
- 002022 Stock
- News Shanghai Kehua Bio-Engineering Co.,Ltd
- Tranche Update on Shanghai Kehua Bio-Engineering Co.,Ltd's Equity Buyback Plan announced on October 29, 2023.